glioblastoma/únava organizmu

Odkaz sa uloží do schránky

Vyberte typ zoradenia

Strana 1 od 20 výsledky

Cognitive Function After Radiation Therapy for Primary Brain Tumours

Články môžu prekladať iba registrovaní používatelia

Prihlásiť Registrácia

RT is fundamental in the treatment of primary brain tumours. RT contributes to improved local control and prolonged progression-free survival in patients with a broad range of tumour types. Irradiation to the normal brain may lead to cognitive impairments. Clarifying the nature and severity of

Restrictive Use of Dexamethasone in Glioblastoma

Články môžu prekladať iba registrovaní používatelia

Prihlásiť Registrácia

Background Glioblastoma (GBM) is the most common and devastating malignant brain tumor in adults. Patients with glioblastoma face a poor prognosis. Despite maximal treatment, most patients suffer tumor progression after 6-7 months and die within 1-2 years. Standard treatment for newly diagnosed

Improving Tumor Treating Fields Treatment for Brain Cancer Patients With Skullremodeling Surgery (Neurosurgery)

Články môžu prekladať iba registrovaní používatelia

Prihlásiť Registrácia

Introduction Tumor treating fields (TTFields) are low-intensity (1-3 v/m) intermediate frequency (200 khz for GBM) alternating fields that disrupt cell division. The treatment is increasingly used as a supplementary modality for patients with glioblastoma (GBM). Recent randomized clinical studies

Memory Perception Assessment in Central/Non-central Nervous System Cancers and HIV

Články môžu prekladať iba registrovaní používatelia

Prihlásiť Registrácia

Primary objective : This study will aim at determining the nature of subjective memory complaints (i.e., prospective or retrospective memory) in cancer patients with intra- cerebral tumors (Glioblastomas and Diffuse Low Grade Gliomas) and extra cerebral tumors (Breast cancer), and in patients with

Pembrolizumab in Association With the IMA950/Poly-ICLC for Relapsing Glioblastoma

Články môžu prekladať iba registrovaní používatelia

Prihlásiť Registrácia

Brain tumors are the first cause of cancer mortality in children and the 3rd cause in young adults. The most frequent brain tumors are gliomas and among them the most common type is astrocytoma. The most malignant astrocytoma is Glioblastoma (GBM). Standard therapy of newly diagnosed GBM patients

Cognitive Function After Radiation Therapy for Brain Tumours

Články môžu prekladať iba registrovaní používatelia

Prihlásiť Registrácia

RT to brain tumours causes cognitive dysfunction. The extent of RT induced changes in cognitive function and radio-sensitivity of the brain is unknown. RT with protons instead of photons spares the healthy brain tissue more and is believed to reduce the risk of cognitive dysfunction. There is modest

Cerebral Morbidity After Radiation Therapy for Brain Tumors

Články môžu prekladať iba registrovaní používatelia

Prihlásiť Registrácia

Feasibility and Preliminary Efficacy of a Mindfulness-based Intervention for Children and Young Adults With High Grade or High-Risk Cancer and Their Caregivers

Články môžu prekladať iba registrovaní používatelia

Prihlásiť Registrácia

Background - Children and young adults diagnosed with a high-grade or high-risk cancer (e.g., diffuse intrinsic pontine glioma, glioblastoma multiforme, relapsed-refractory leukemia, refractory metastatic sarcomas) face a poor prognosis given limited curative options. - Recent research has indicated

Exercise in Patients With Glioblastoma

Články môžu prekladať iba registrovaní používatelia

Prihlásiť Registrácia

Background: Glioblastoma (GBM) is the most common malignant glioma in adults, with a very poor prognosis, limited new treatment options, and neurological sequelae, including physical and cognitive decline that adversely affect quality of life (QOL). Physical activity may be an intervention that

Tumor Resection and Gliadel® Wafers, Followed by Temodar® With Standard Radiation or GammaKnife® for New GBM

Články môžu prekladať iba registrovaní používatelia

Prihlásiť Registrácia

The primary purpose of this study is to determine if single fraction GK radiosurgical treatment to the resection bed can achieve equivalent local control and survival for patients with GBM after GTR, Gliadel® implant and temozolomide therapy compared to patients receiving standard postoperative RT

Anti PD1 Antibody in Diffuse Intrinsic Pontine Glioma

Články môžu prekladať iba registrovaní používatelia

Prihlásiť Registrácia

1. Diffuse intrinsic pontine glioma Diffuse intrinsic pontine glioma (DIPG) is the most lethal pediatric malignant disease. Children are usually diagnosed at the age of 6-8 years following a short history of neurological deterioration with often a combination of cranial nerve dysfunction, ataxia and

Re-irradiation of High Grade Gliomas: a Quality of Life Study

Články môžu prekladať iba registrovaní používatelia

Prihlásiť Registrácia

Current treatment regimes, with the addition of temozolomide, have improved progression-free survival as well as overall survival for patients with a high grade glioma. The median overall survival (MOS) for patients with a glioblastoma (GBM) is 14.6 months, with a progression free survival (PFS) of

Efficacy of Hypofractionated XRT w/Bev. + Temozolomide for Recurrent Gliomas

Články môžu prekladať iba registrovaní používatelia

Prihlásiť Registrácia

PRIMARY OBJECTIVES: I. To determine the overall survival (OS) for patients with recurrent high grade malignant gliomas treated with concurrent radiation, temozolomide, and bevacizumab followed by adjuvant temozolomide and bevacizumab. SECONDARY OBJECTIVES: I. Determine the impact of this regimen on

Dose Evaluation Safety STudy IN Individuals With Astrocytoma Taking PolyMVA

Články môžu prekladať iba registrovaní používatelia

Prihlásiť Registrácia

This is a Phase I Safety Study which investigates the role of PolyMVA as a supplement in grade IV astrocytoma patients. The primary endpoint of this study is safety/tolerability. This supplement, PolyMVA, is a uniquely formulated combination of minerals, vitamins, and amino acids. The principle

Low-dose (12 Gy) TSEBT+Vorinostat Versus Low-dose TSEBT Monotherapy in Mycosis Fungoides

Články môžu prekladať iba registrovaní používatelia

Prihlásiť Registrácia

Vorinostat is a histone deacetylase inhibitor (HDAC) that is FDA-approved for treatment of mycosis fungoides (MF), and has shown activity as a radiation-sensitizer in preclinical studies. Treatment of various cell lines [glioblastoma multiforme (GBM), non-small cell lung cancer (NSCLC), melanoma]

Predchádzajúce
1
2
Ďalšie

Pripojte sa k našej
facebookovej stránke

Herbal & Natural Medicine

Najkompletnejšia databáza liečivých bylín podporovaná vedou

Pracuje v 55 jazykoch
Bylinné lieky podporené vedou
Rozpoznávanie bylín podľa obrázka
Interaktívna GPS mapa - označte byliny na mieste (už čoskoro)
Prečítajte si vedecké publikácie týkajúce sa vášho hľadania
Vyhľadajte liečivé byliny podľa ich účinkov
Usporiadajte svoje záujmy a držte krok s novinkami, klinickými skúškami a patentmi

Zadajte príznak alebo chorobu a prečítajte si o bylinách, ktoré by vám mohli pomôcť, napíšte bylinu a pozrite sa na choroby a príznaky, proti ktorým sa používa.
* Všetky informácie sú založené na publikovanom vedeckom výskume